{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:29:31Z","timestamp":1784323771716,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cytogenet"],"DOI":"10.1186\/s13039-025-00744-1","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:03:24Z","timestamp":1766149404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optical genome mapping identifies novel ENOX2::RUNX1 t(X;21)(q26.1;q22.12) rearrangement in acute myeloid leukemia-myelodysplasia related: first case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Giby V.","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarmad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chauncey R.","family":"Syposs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Anwar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"11","key":"744_CR1","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi AP, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200\u201328. https:\/\/doi.org\/10.1182\/blood.2022015850.","journal-title":"Blood"},{"issue":"7","key":"744_CR2","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and Histiocytic\/Dendritic neoplasms. Leukemia. 2022;36(7):1703\u201319. https:\/\/doi.org\/10.1038\/s41375-022-01613-1.","journal-title":"Leukemia"},{"issue":"7","key":"744_CR3","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41375-023-01909-w","volume":"37","author":"S Huber","year":"2023","unstructured":"Huber S, Baer C, Hutter S, Dicker F, Meggendorfer M, Pohlkamp C, et al. AML classification in the year 2023: how to avoid a Babylonian confusion of languages. Leukemia. 2023;37(7):1413\u201320. https:\/\/doi.org\/10.1038\/s41375-023-01909-w.","journal-title":"Leukemia"},{"issue":"17","key":"744_CR4","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1182\/bloodadvances.2023010173","volume":"7","author":"S Travaglini","year":"2023","unstructured":"Travaglini S, Pascale MR, Awada H, Durmaz A, Visconte V, Della Porta MG, et al. Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting. Blood Adv. 2023;7(17):5122\u201331. https:\/\/doi.org\/10.1182\/bloodadvances.2023010173.","journal-title":"Blood Adv"},{"issue":"1","key":"744_CR5","doi-asserted-by":"publisher","first-page":"101533","DOI":"10.1016\/j.beha.2023.101533","volume":"37","author":"O Snaith","year":"2024","unstructured":"Snaith O, Poveda-Rogers C, Laczko D, Yang G, Morrissette JJD. Cytogenetics and genomics of acute myeloid leukemia. Best Pract Res Clin Haematol. 2024;37(1):101533. https:\/\/doi.org\/10.1016\/j.beha.2023.101533.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"744_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/gcc.22036","volume":"52","author":"A Walker","year":"2013","unstructured":"Walker A, Mr\u00f3zek K, Kohlschmidt J, Rao KW, Pettenati MJ, Sterling LJ, et al. New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: cancer and leukemia group B 8461. Genes Chromosomes Cancer. 2013;52(4):385\u2013401. https:\/\/doi.org\/10.1002\/gcc.22036.","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"744_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ng1335","volume":"36","author":"F Mitelman","year":"2004","unstructured":"Mitelman F, Johansson B, Mertens F. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet. 2004;36(4):331\u20134. https:\/\/doi.org\/10.1038\/ng1335.","journal-title":"Nat Genet"},{"issue":"11","key":"744_CR8","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.3390\/cancers15112942","volume":"15","author":"M Tembrink","year":"2023","unstructured":"Tembrink M, Gerding WM, Wieczorek S, Mika T, Schroers R, Nguyen HP, et al. Novel NUP98::ASH1L gene fusion in acute myeloid leukemia detected by optical genome mapping. Cancers (Basel). 2023;15(11):2942. https:\/\/doi.org\/10.3390\/cancers15112942.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"744_CR9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1182\/bloodadvances.2022007583","volume":"7","author":"B Levy","year":"2023","unstructured":"Levy B, Baughn LB, Akkari Y, Chartrand S, LaBarge B, Claxton D, et al. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation. Blood Adv. 2023;7(7):1297\u2013307. https:\/\/doi.org\/10.1182\/bloodadvances.2022007583.","journal-title":"Blood Adv"},{"issue":"1","key":"744_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/genes16010007","volume":"16","author":"GV George","year":"2024","unstructured":"George GV, Elsadawi M, Evans AG, Ali S, Zhang B, Iqbal MA. Utilization of RT-PCR and optical genome mapping in acute promyelocytic leukemia with cryptic PML::RARA rearrangement: a case discussion and systemic literature review. Genes (Basel). 2024;16(1):7. https:\/\/doi.org\/10.3390\/genes16010007.","journal-title":"Genes (Basel)"},{"issue":"12","key":"744_CR11","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.3390\/ijms26125763","volume":"26","author":"L Ballesta-Alcaraz","year":"2025","unstructured":"Ballesta-Alcaraz L, Bernal M, Vilchez JR, Palacios JA, Jim\u00e9nez P, Garrido P, et al. Application of optical genome mapping for the diagnosis and risk stratification of myeloid and lymphoid malignancies. Int J Mol Sci. 2025;26(12):5763. https:\/\/doi.org\/10.3390\/ijms26125763.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"744_CR12","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/ajh.27435","volume":"99","author":"S Loghavi","year":"2024","unstructured":"Loghavi S, Wei Q, Ravandi F, Quesada AE, Routbort MJ, Hu S, et al. Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia. Am J Hematol. 2024;99(10):1959\u201368. https:\/\/doi.org\/10.1002\/ajh.27435.","journal-title":"Am J Hematol"},{"issue":"11","key":"744_CR13","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3390\/genes15111402","volume":"15","author":"M Klausner","year":"2024","unstructured":"Klausner M, Stinnett V, Ghabrial J, Morsberger L, DeMetrick N, Long P, et al. Optical genome mapping reveals complex and cryptic rearrangement involving PML::RARA fusion in acute promyelocytic leukemia. Genes (Basel). 2024;15(11):1402. https:\/\/doi.org\/10.3390\/genes15111402.","journal-title":"Genes (Basel)"},{"issue":"15","key":"744_CR14","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","volume":"129","author":"R Sood","year":"2017","unstructured":"Sood R, Kamikubo Y, Liu P. Role of RUNX1 in hematological malignancies. Blood. 2017;129(15):2070\u201382. https:\/\/doi.org\/10.1182\/blood-2016-10-687830.","journal-title":"Blood"},{"issue":"2","key":"744_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.14348\/molcells.2019.0252","volume":"43","author":"A Yokota","year":"2020","unstructured":"Yokota A, Huo L, Lan F, Wu J, Huang G. The clinical, molecular, and mechanistic basis of RUNX1 mutations identified in hematological malignancies. Mol Cells. 2020;43(2):145\u201352. https:\/\/doi.org\/10.14348\/molcells.2019.0252.","journal-title":"Mol Cells"},{"issue":"2","key":"744_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/gcc.22901","volume":"60","author":"U Aypar","year":"2021","unstructured":"Aypar U, Yao J, Londono DM, Khoobyar R, Scalise A, Arcila ME, et al. Rare and novel RUNX1 fusions in myeloid neoplasms: a single-institute experience. Genes Chromosomes Cancer. 2021;60(2):100\u20137. https:\/\/doi.org\/10.1002\/gcc.22901.","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"744_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/gcc.22829","volume":"59","author":"J Flach","year":"2020","unstructured":"Flach J, Shumilov E, Joncourt R, Porret N, Tchinda J, Legros M, et al. Detection of rare reciprocal RUNX1 rearrangements by next-generation sequencing in acute myeloid leukemia. Genes Chromosomes Cancer. 2020;59(4):268\u201374. https:\/\/doi.org\/10.1002\/gcc.22829.","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"744_CR18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/1071576031000083107","volume":"37","author":"DJ Morr\u00e9","year":"2003","unstructured":"Morr\u00e9 DJ, Morr\u00e9 DM. Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative diseases. Free Radic Res. 2003;37(8):795\u2013808. https:\/\/doi.org\/10.1080\/1071576031000083107.","journal-title":"Free Radic Res"},{"key":"744_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-3958-5","volume-title":"Growth, Cancer, and aging","author":"JD Morre","year":"2012","unstructured":"Morre JD, Morre DM, ECTO-NOX Proteins. Growth, Cancer, and aging. New York: Springer; 2012. https:\/\/doi.org\/10.1007\/978-1-4614-3958-5."},{"key":"744_CR20","doi-asserted-by":"publisher","unstructured":"ISCN. 2024: An International System for Human Cytogenomic Nomenclature (2024). Cytogenet Genome Res. 2024;164(Suppl 1):1\u2013224. https:\/\/doi.org\/10.1159\/000538512","DOI":"10.1159\/000538512"},{"issue":"6","key":"744_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/genes16060684","volume":"16","author":"EA Blake","year":"2025","unstructured":"Blake EA, Ramineni M, Oltvai ZN. A modified FLT3 PCR assay using a tapestation readout. Genes (Basel). 2025;16(6):684. https:\/\/doi.org\/10.3390\/genes16060684.","journal-title":"Genes (Basel)"},{"issue":"12","key":"744_CR22","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.3390\/biomedicines11123263","volume":"11","author":"AWC Pang","year":"2023","unstructured":"Pang AWC, Kosco K, Sahajpal NS, Sridhar A, Hauenstein J, Clifford B, et al. Analytic validation of optical genome mapping in hematological malignancies. Biomedicines. 2023;11(12):3263. https:\/\/doi.org\/10.3390\/biomedicines11123263.","journal-title":"Biomedicines"},{"issue":"2","key":"744_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1365-2141.2006.06276.x","volume":"135","author":"FR Appelbaum","year":"2006","unstructured":"Appelbaum FR, Kopecky KJ, Tallman MS, Slovak ML, Gundacker HM, Kim HT, et al. The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations. Br J Haematol. 2006;135(2):165\u201373. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06276.x.","journal-title":"Br J Haematol"},{"issue":"28","key":"744_CR24","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1200\/JCO.2008.21.0674","volume":"27","author":"T Pr\u00e9bet","year":"2009","unstructured":"Pr\u00e9bet T, Boissel N, Reutenauer S, Thomas X, Delaunay J, Cahn JY, et al. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup. J Clin Oncol. 2009;27(28):4747\u201353. https:\/\/doi.org\/10.1200\/JCO.2008.21.0674.","journal-title":"J Clin Oncol"},{"issue":"1","key":"744_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1309\/AJCPZRRL2DGC2ODA","volume":"138","author":"S Li","year":"2012","unstructured":"Li S, Yin CC, Medeiros LJ, Bueso-Ramos C, Lu G, Lin P. Myelodysplastic syndrome\/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome. Am J Clin Pathol. 2012;138(1):146\u201352. https:\/\/doi.org\/10.1309\/AJCPZRRL2DGC2ODA.","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"744_CR26","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/ajh.27340","volume":"99","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Zhuo N, Zhou Y, Sun C, Yao Y, Mao L, et al. Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients. Am J Hematol. 2024;99(7):1441\u20134. https:\/\/doi.org\/10.1002\/ajh.27340.","journal-title":"Am J Hematol"},{"issue":"1","key":"744_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2217\/fon.10.158","volume":"7","author":"E De Braekeleer","year":"2011","unstructured":"De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris MJ, F\u00e9rec C, De Braekeleer M. RUNX1 translocations and fusion genes in malignant hemopathies. Future Oncol. 2011;7(1):77\u201391. https:\/\/doi.org\/10.2217\/fon.10.158.","journal-title":"Future Oncol"},{"issue":"1","key":"744_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12014-008-9016-x","volume":"5","author":"B Hostetler","year":"2009","unstructured":"Hostetler B, Weston N, Kim C, Morr\u00e9 DM, Morr\u00e9 DJ. Cancer site-specific isoforms of ENOX2 (tNOX), a cancer-specific cell surface oxidase. Clin Proteom. 2009;5(1):46\u201351. https:\/\/doi.org\/10.1007\/s12014-008-9016-x.","journal-title":"Clin Proteom"},{"issue":"14 Suppl","key":"744_CR29","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1158\/1538-7445.AM2016-3984","volume":"76","author":"L Johnson","year":"2016","unstructured":"Johnson L, Wang H, Trifilo K, Kudlow B, Pappenhausen PR, Hussaini M. Novel t(X;21)(q26;q22) detected in a case of acute unclassifiable leukemia by application of anchored multiplex PCR-based next-generation sequencing. Cancer Res. 2016;76(14 Suppl):3984. https:\/\/doi.org\/10.1158\/1538-7445.AM2016-3984.","journal-title":"Cancer Res"},{"key":"744_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-1-4614-3958-5_11","volume-title":"ECTO-NOX proteins","author":"DJ Morr\u00e9","year":"2012","unstructured":"Morr\u00e9 DJ, Morr\u00e9 DM. Cancer therapeutic applications of ENOX2 proteins. In: Morr\u00e9 DJ, Morr\u00e9 DM, editors. ECTO-NOX proteins. New York: Springer; 2012. pp. 211\u201327. https:\/\/doi.org\/10.1007\/978-1-4614-3958-5_11."},{"issue":"1","key":"744_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41408-023-00826-6","volume":"13","author":"W Fiskus","year":"2023","unstructured":"Fiskus W, Mill CP, Birdwell C, Davis JA, Das K, Boettcher S, et al. Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. Blood Cancer J. 2023;13(1):53. https:\/\/doi.org\/10.1038\/s41408-023-00826-6.","journal-title":"Blood Cancer J"},{"issue":"9","key":"744_CR32","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1038\/sj.emboj.7601675","volume":"26","author":"T Fujimoto","year":"2007","unstructured":"Fujimoto T, Anderson K, Jacobsen S, Nishikawa S, Nerlov C. Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C\/EBP\u03b1 interaction. EMBO J. 2007;26(9):2361\u201370. https:\/\/doi.org\/10.1038\/sj.emboj.7601675.","journal-title":"EMBO J"},{"issue":"14","key":"744_CR33","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1182\/bloodadvances.2023011771","volume":"8","author":"RE van Weelderen","year":"2024","unstructured":"van Weelderen RE, Harrison CJ, Klein K, Jiang Y, Abrahamsson J, Alonzo T, et al. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia. Blood Adv. 2024;8(14):3200\u201313. https:\/\/doi.org\/10.1182\/bloodadvances.2023011771.","journal-title":"Blood Adv"},{"issue":"3","key":"744_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/onco3030011","volume":"3","author":"S Mohanty","year":"2023","unstructured":"Mohanty S. NUP98 rearrangements in AML: molecular mechanisms and clinical implications. Onco. 2023;3(3):147\u201364. https:\/\/doi.org\/10.3390\/onco3030011.","journal-title":"Onco"},{"issue":"1","key":"744_CR35","doi-asserted-by":"publisher","first-page":"2483094","DOI":"10.1080\/16078454.2025.2483094","volume":"30","author":"M Sandnes","year":"2025","unstructured":"Sandnes M, Sefland \u00d8, Ktoridou-Valen I, Brendsdal Forthun R, Kollsete Gjelberg H, Dahl Hamnvik LH, et al. RUNX1::MECOM rearrangement in myeloid neoplasm post cytotoxic therapy following sarcoma treatment: a case presentation and review of the literature. Hematology. 2025;30(1):2483094. https:\/\/doi.org\/10.1080\/16078454.2025.2483094.","journal-title":"Hematology"}],"container-title":["Molecular Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13039-025-00744-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-025-00744-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-025-00744-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:34:29Z","timestamp":1769171669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13039-025-00744-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["744"],"URL":"https:\/\/doi.org\/10.1186\/s13039-025-00744-1","relation":{},"ISSN":["1755-8166"],"issn-type":[{"value":"1755-8166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board (IRB) approval was not necessary for this single case report. Informed consent was waived as no patient identifying information has been included.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was waived per the IRB as no patient identifying information has been included.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}